Developer docs
API playgroundTry for free, no card

Search company profiles

Alphial

Full company profile

uuid0007t53

Namestring
Alphial
Legal namestring
Alphial Srl
Websiteurl
alphial.eu
Company typeenum
Private
Founded yearint
1964
Descriptiontext

Alphial is an Italian manufacturer of primary glass packaging for the pharmaceutical industry, producing tubular glass ampoules, vials, ready-to-use sterile vials, droppers, ampoule breakers, and closures. Founded in 1964 and headquartered in Treviglio (Bergamo), the company operates manufacturing sites in Felino (Parma), Bernareggio (Monza Brianza), and Ponte Valleceppi (Perugia), and was further expanded in February 2024 through the acquisitions of Italian tubular glass converters Sicatef and Luxenia. Following these acquisitions, Alphial operates 5 sites and 61 production lines with annual capacity exceeding 1 billion pieces, and it is described as the largest European manufacturer of glass ampoules and vials for pharmaceutical and cosmetic applications.

The company's core technology is proprietary sterilization and depyrogenation, centered on the patented LS5 process (which uses only air and water to deliver ampoules and vials ready for filling) and the LW7 light wash process conducted in ISO 7 (Grade C) and packaged under ISO 5 (Grade A) aseptic conditions, achieving a sterility assurance level of 10^-6 without ethylene oxide. Quality is anchored by ISO 9001 and ISO 15378 certifications, the latter specific to primary packaging materials for pharmaceuticals, and the company maintains in-line and off-line visual and dimensional inspection systems.

Alphial operates a B2B hardware sales model, selling directly to pharmaceutical manufacturers via enterprise sales relationships and generating leads through major industry events (CPHI, Pharmapack, Pharmap Congress, Maghreb Pharma Expo). Pricing is quote-based and not publicly disclosed, and the company also offers contract sterilization services for third-party vials. As of Q4 2025, Alphial is a wholly-owned subsidiary of SGD Pharma (backed by PAI) following an acquisition from prior owners Entangled Capital and Capital Dynamics, subject to Italian FDI clearance, and serves as an important European hub for tubular glass converting within the SGD Group.

Short descriptiontext

Alphial is an Italian manufacturer of primary tubular glass packaging (ampoules, vials, and ready-to-use sterile vials) for pharmaceutical companies, operating 5 sites and 61 production lines as the largest European producer of glass ampoules and vials, now a subsidiary of SGD Pharma.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersTreviglio, Italy
HQ citystring
Treviglio
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical glass packaging, tubular glass vials, sterile glass ampoules, primary packaging manufacturing, injectable drug containers
Industry3 codes
PRIMARYIMALAEAB
Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes)
SECONDARYIMALAIAA
Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules)
SECONDARYIMALAIAB
Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers)
NAICS code2 codes
  • Glass Container Manufacturing327213
  • Other Pressed and Blown Glass and Glassware Manufacturing327212
SIC code2 codes
  • Glass Containers3221
  • Glass & Glassware, Pressed Or Blown3220
Product category
Pharmaceutical Glass Packaging
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Glass Packaging
TypeHardware Sales
Description

Manufacture and sale of primary glass packaging products including ampoules, vials, sterile vials, droppers, ampoule breakers, and closures for pharmaceutical and biotech applications. Also offers contract sterilization services for vials manufactured by third parties.

alphial.eu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Alphial manufactures primary glass packaging for the pharmaceutical industry, producing tubular glass ampoules, vials, sterile ready-to-use vials, droppers, ampoule breakers, and closures designed to contain injectable drugs and biotech solutions. The company operates proprietary patented sterilization processes — LS5 (sterilization and depyrogenation using only air and water) and LW7 (light wash in ISO 7 environment) — that deliver sterile, depyrogenated vials ready for direct integration into customer filling lines, and also offers contract sterilization services for third-party vials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Sterility assurance level of 10⁻⁶ achieved without ethylene oxide
Product overview1 text field

Alphial is a primary glass packaging manufacturer for the pharmaceutical industry, producing a comprehensive portfolio of tubular glass products including glass ampoules, glass vials, sterile vials (Ready-to-Use), droppers and ampoule breakers, and closures. The company operates proprietary patented sterilization processes including LS5 (sterilization and depyrogenation using air and water) and LW7 (light wash in ISO 7 environment). Following acquisitions of Sicatef and Luxenia, Alphial consolidated historic Italian centers of excellence in tubular glass converting, becoming the largest European manufacturer of glass ampoules and vials for pharmaceutical and cosmetic applications. The company was acquired by SGD Pharma in Q4 2025, strengthening its position in the European tubular glass market.

Product and service6 records
1Glass Ampoules
CategoryPharmaceutical Glass Packaging
Description

Tubular glass ampoules available in multiple formats and closure types for pharmaceutical primary packaging applications, used to contain injectable drugs and biotech solutions.

2Glass Vials
CategoryPharmaceutical Glass Packaging
Description

Type I tubular glass vials available in multiple colors, capacities, heights, and diameters, designed for containing injectable drugs and biotech solutions while preserving drug efficacy and stability.

3Sterile Vials (Ready-to-Use)
CategoryPharmaceutical Glass Packaging
Description

Type I tubular glass vials that are washed, sterilized via the LW7 light wash process, depyrogenated, and packaged under aseptic conditions, ready for direct integration into pharmaceutical filling lines without additional customer handling.

4Droppers and Ampoule Breakers
CategoryPharmaceutical Packaging Accessories
Description

Functional and reliable closure accessories designed to complete pharmaceutical glass packaging solutions, including droppers and ampoule breakers.

5Closures
CategoryPharmaceutical Packaging Accessories
Description

Closure products designed for completing pharmaceutical glass packaging solutions across ampoule and vial formats.

6Contract Sterilization Services for Third-Party Vials
CategorySterilization Services
Description

Sterilization and depyrogenation services performed by Alphial on vials manufactured by third parties, leveraging the proprietary LS5 air-and-water process.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-28
Description

French group and global leader in primary pharmaceutical glass packaging. Acquired Alphial in Q4 2025 to strengthen its tubular glass leadership. Alphial represents an important European hub for tubular glass converting within the SGD Group.

2Sicatef
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-28
Description

Company acquired by Alphial in February 2024, adding to Alphial Group. Maintains distinct corporate identity while sharing values and objectives.

alphial.eu
3Luxenia
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-28
Description

Company acquired by Alphial in February 2024, adding to Alphial Group. Maintains distinct corporate identity while sharing values and objectives.

alphial.eu
Strategic tierMinorTypeOthers
Description

Collaboration with DHL in their GoGreen program to reduce CO2 emissions. Alphial received Climate Neutral Certificate 2021 through this partnership.

5Cooperativa La Bula
Strategic tierMinorTypeOthers
Description

Parma-based cooperative that assembled Christmas gift packages for Alphial employees, contributing to social integration for people with disabilities.

alphial.eu
6Verso il Sereno / C.A.P.O. Project
Strategic tierMinorTypeOthers
Description

Charitable initiative supported by Alphial through Christmas gift packages, providing assistance to cancer patients requiring home care support.

alphial.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for Alphial Academy training program focused on lean organization and continuous improvement methodologies. Employees participate in workshops to identify waste (Muda) and develop lean working methods.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German-headquartered global manufacturer of primary packaging for pharma and cosmetics, including glass vials, ampoules, and syringes. Directly comparable product portfolio, customer base (pharmaceutical manufacturers), and tubular/molded glass converting capabilities.

TypeEmerging player
Description

Global supplier of dispensing systems and packaging components for pharmaceutical, beauty, and food applications. Adjacent player offering closures and delivery systems that complement glass primary packaging for injectables and other drug formats.

TypeBroad incumbent
Description

Global medical technology company with pharmaceutical systems business producing prefillable syringes, vials, and drug delivery devices. Comparable offerings in injectable primary packaging and broad pharmaceutical customer relationships.

4Corning Incorporated
TypeBroad incumbent
Description

US-based specialty glass and ceramics manufacturer with pharmaceutical glass packaging (Corning Pharmaceutical Technologies) producing vials and drug containment solutions. Broad incumbent in pharmaceutical primary packaging.

TypeBroad incumbent
Description

US-based global manufacturer of injectable drug containment and delivery solutions including elastomeric closures, vials, and syringe components. Comparable primary packaging solutions for injectable pharmaceutical customers.

TypeBroad incumbent
Description

French global leader in primary pharmaceutical glass packaging and Alphial's parent company following the Q4 2025 acquisition. Comparable molded and tubular glass product portfolio serving pharma customers across broader geographies.

TypeDirect peer
Description

Italian pharmaceutical glass packaging and drug containment solutions provider offering vials, syringes, and inspection systems. Direct competitor in tubular glass vials and ready-to-use sterile primary packaging serving pharma and biotech customers.

TypeDirect peer
Description

Manufacturer of specialty glass packaging including pharmaceutical ampoules, vials, and bottles for life sciences applications. Comparable tubular glass converting capabilities and customer base in pharma and laboratory markets.

TypeDirect peer
Description

German specialty glass manufacturer with a dedicated pharmaceutical packaging business (Schott Pharma) producing vials, ampoules, syringes, and cartridges. Direct competitor with overlapping Type I glass primary packaging portfolio and similar pharmaceutical customer base.

10Nipro Corporation
TypeDirect peer
Description

Japanese global medical device and pharmaceutical packaging manufacturer with glass tubular products (ampoules, vials). Comparable product offerings for pharmaceutical primary packaging and overlap in injectable drug delivery.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alphial

Pharmaceutical Glass Packagingalphial.eu

Alphial is an Italian manufacturer of primary tubular glass packaging (ampoules, vials, and ready-to-use sterile vials) for pharmaceutical companies, operating 5 sites and 61 production lines as the largest European producer of glass ampoules and vials, now a subsidiary of SGD Pharma.

What Alphial does

Alphial is an Italian manufacturer of primary glass packaging for the pharmaceutical industry, producing tubular glass ampoules, vials, ready-to-use sterile vials, droppers, ampoule breakers, and closures. Founded in 1964 and headquartered in Treviglio (Bergamo), the company operates manufacturing sites in Felino (Parma), Bernareggio (Monza Brianza), and Ponte Valleceppi (Perugia), and was further expanded in February 2024 through the acquisitions of Italian tubular glass converters Sicatef and Luxenia. Following these acquisitions, Alphial operates 5 sites and 61 production lines with annual capacity exceeding 1 billion pieces, and it is described as the largest European manufacturer of glass ampoules and vials for pharmaceutical and cosmetic applications.

The company's core technology is proprietary sterilization and depyrogenation, centered on the patented LS5 process (which uses only air and water to deliver ampoules and vials ready for filling) and the LW7 light wash process conducted in ISO 7 (Grade C) and packaged under ISO 5 (Grade A) aseptic conditions, achieving a sterility assurance level of 10^-6 without ethylene oxide. Quality is anchored by ISO 9001 and ISO 15378 certifications, the latter specific to primary packaging materials for pharmaceuticals, and the company maintains in-line and off-line visual and dimensional inspection systems.

Alphial operates a B2B hardware sales model, selling directly to pharmaceutical manufacturers via enterprise sales relationships and generating leads through major industry events (CPHI, Pharmapack, Pharmap Congress, Maghreb Pharma Expo). Pricing is quote-based and not publicly disclosed, and the company also offers contract sterilization services for third-party vials. As of Q4 2025, Alphial is a wholly-owned subsidiary of SGD Pharma (backed by PAI) following an acquisition from prior owners Entangled Capital and Capital Dynamics, subject to Italian FDI clearance, and serves as an important European hub for tubular glass converting within the SGD Group.

Alphial firmographics

Firmographics
Name
Alphial
Legal name
Alphial Srl
Website
https://alphial.eu
Company type
Private
Founded year
1964
Operating status
Operating
Headcount range
51–100 employees
Short description
Alphial is an Italian manufacturer of primary tubular glass packaging (ampoules, vials, and ready-to-use sterile vials) for pharmaceutical companies, operating 5 sites and 61 production lines as the largest European producer of glass ampoules and vials, now a subsidiary of SGD Pharma.
Ownership category
akta.pro rank

Alphial industry classification

Industry
Product category
Pharmaceutical Glass Packaging
NAICS
Glass Container Manufacturing (327213), Other Pressed and Blown Glass and Glassware Manufacturing (327212)
SIC
Glass Containers (3221), Glass & Glassware, Pressed Or Blown (3220)
akta.pro industry
PRIMARYIMALAEAB
Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes)
SECONDARYIMALAIAA
Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules)
SECONDARYIMALAIAB
Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers)

Keywords

  • Pharmaceutical glass packaging
  • Tubular glass vials
  • Sterile glass ampoules
  • Primary packaging manufacturing
  • Injectable drug containers

Where Alphial is headquartered

Location

Headquarters

HQ city
Treviglio
HQ country
Italy
HQ region
Europe

Offices4 records

Markets served

Alphial business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Pharmaceutical Glass Packaging: Manufacture and sale of primary glass packaging products including ampoules, vials, sterile vials, droppers, ampoule breakers, and closures for pharmaceutical and biotech applications. Also offers contract sterilization services for vials manufactured by third parties.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Alphial product offering

Product offering

Core offering

Alphial manufactures primary glass packaging for the pharmaceutical industry, producing tubular glass ampoules, vials, sterile ready-to-use vials, droppers, ampoule breakers, and closures designed to contain injectable drugs and biotech solutions. The company operates proprietary patented sterilization processes — LS5 (sterilization and depyrogenation using only air and water) and LW7 (light wash in ISO 7 environment) — that deliver sterile, depyrogenated vials ready for direct integration into customer filling lines, and also offers contract sterilization services for third-party vials.

Product overview

Alphial is a primary glass packaging manufacturer for the pharmaceutical industry, producing a comprehensive portfolio of tubular glass products including glass ampoules, glass vials, sterile vials (Ready-to-Use), droppers and ampoule breakers, and closures. The company operates proprietary patented sterilization processes including LS5 (sterilization and depyrogenation using air and water) and LW7 (light wash in ISO 7 environment). Following acquisitions of Sicatef and Luxenia, Alphial consolidated historic Italian centers of excellence in tubular glass converting, becoming the largest European manufacturer of glass ampoules and vials for pharmaceutical and cosmetic applications. The company was acquired by SGD Pharma in Q4 2025, strengthening its position in the European tubular glass market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Glass Ampoules Tubular glass ampoules available in multiple formats and closure types for pharmaceutical primary packaging applications, used to contain injectable drugs and biotech solutions.
  • Glass Vials Type I tubular glass vials available in multiple colors, capacities, heights, and diameters, designed for containing injectable drugs and biotech solutions while preserving drug efficacy and stability.
  • Sterile Vials (Ready-to-Use) Type I tubular glass vials that are washed, sterilized via the LW7 light wash process, depyrogenated, and packaged under aseptic conditions, ready for direct integration into pharmaceutical filling lines without additional customer handling.
  • Droppers and Ampoule Breakers Functional and reliable closure accessories designed to complete pharmaceutical glass packaging solutions, including droppers and ampoule breakers.
  • Closures Closure products designed for completing pharmaceutical glass packaging solutions across ampoule and vial formats.
  • Contract Sterilization Services for Third-Party Vials Sterilization and depyrogenation services performed by Alphial on vials manufactured by third parties, leveraging the proprietary LS5 air-and-water process.

Quantifiable outcome

  • Sterility assurance level of 10⁻⁶ achieved without ethylene oxide

Companies that use Alphial

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Alphial technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Alphial partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • SGD PharmacoreStrategic or Co-development Partner · 28 August 2025French group and global leader in primary pharmaceutical glass packaging. Acquired Alphial in Q4 2025 to strengthen its tubular glass leadership. Alphial represents an important European hub for tubular glass converting within the SGD Group.
  • SicatefcoreStrategic or Co-development Partner · 28 February 2024Company acquired by Alphial in February 2024, adding to Alphial Group. Maintains distinct corporate identity while sharing values and objectives.
  • LuxeniacoreStrategic or Co-development Partner · 28 February 2024Company acquired by Alphial in February 2024, adding to Alphial Group. Maintains distinct corporate identity while sharing values and objectives.
  • DHL GoGreen ProgramminorOthersCollaboration with DHL in their GoGreen program to reduce CO2 emissions. Alphial received Climate Neutral Certificate 2021 through this partnership.
  • Cooperativa La BulaminorOthersParma-based cooperative that assembled Christmas gift packages for Alphial employees, contributing to social integration for people with disabilities.
  • Verso il Sereno / C.A.P.O. ProjectminorOthersCharitable initiative supported by Alphial through Christmas gift packages, providing assistance to cancer patients requiring home care support.
  • Kaizen InstitutecoreStrategic or Co-development PartnerPartnership for Alphial Academy training program focused on lean organization and continuous improvement methodologies. Employees participate in workshops to identify waste (Muda) and develop lean working methods.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Alphial competitors and assessment

Company assessment

Direct peers

  • Gerresheimer AG: German-headquartered global manufacturer of primary packaging for pharma and cosmetics, including glass vials, ampoules, and syringes. Directly comparable product portfolio, customer base (pharmaceutical manufacturers), and tubular/molded glass converting capabilities.
  • Stevanato Group: Italian pharmaceutical glass packaging and drug containment solutions provider offering vials, syringes, and inspection systems. Direct competitor in tubular glass vials and ready-to-use sterile primary packaging serving pharma and biotech customers.
  • DWK Life Sciences: Manufacturer of specialty glass packaging including pharmaceutical ampoules, vials, and bottles for life sciences applications. Comparable tubular glass converting capabilities and customer base in pharma and laboratory markets.
  • Schott AG (Schott Pharma): German specialty glass manufacturer with a dedicated pharmaceutical packaging business (Schott Pharma) producing vials, ampoules, syringes, and cartridges. Direct competitor with overlapping Type I glass primary packaging portfolio and similar pharmaceutical customer base.
  • Nipro Corporation: Japanese global medical device and pharmaceutical packaging manufacturer with glass tubular products (ampoules, vials). Comparable product offerings for pharmaceutical primary packaging and overlap in injectable drug delivery.

Emerging players

  • AptarGroup: Global supplier of dispensing systems and packaging components for pharmaceutical, beauty, and food applications. Adjacent player offering closures and delivery systems that complement glass primary packaging for injectables and other drug formats.

Broad incumbents

  • Becton, Dickinson and Company (BD): Global medical technology company with pharmaceutical systems business producing prefillable syringes, vials, and drug delivery devices. Comparable offerings in injectable primary packaging and broad pharmaceutical customer relationships.
  • Corning Incorporated: US-based specialty glass and ceramics manufacturer with pharmaceutical glass packaging (Corning Pharmaceutical Technologies) producing vials and drug containment solutions. Broad incumbent in pharmaceutical primary packaging.
  • West Pharmaceutical Services: US-based global manufacturer of injectable drug containment and delivery solutions including elastomeric closures, vials, and syringe components. Comparable primary packaging solutions for injectable pharmaceutical customers.
  • SGD Pharma: French global leader in primary pharmaceutical glass packaging and Alphial's parent company following the Q4 2025 acquisition. Comparable molded and tubular glass product portfolio serving pharma customers across broader geographies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Alphial social profiles

Digital presence

Alphial compliance and trust

Trust signal

Compliance4 records

Alphial financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alphial leadership team

Management profile

Number of profiles

Profiles1 record

Alphial subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Alphial funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alphial M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alphial

What does Alphial do?

Alphial manufactures primary glass packaging for the pharmaceutical industry, producing tubular glass ampoules, vials, sterile ready-to-use vials, droppers, ampoule breakers, and closures designed to contain injectable drugs and biotech solutions. The company operates proprietary patented sterilization processes — LS5 (sterilization and depyrogenation using only air and water) and LW7 (light wash in ISO 7 environment) — that deliver sterile, depyrogenated vials ready for direct integration into customer filling lines, and also offers contract sterilization services for third-party vials.

Is Alphial a public or private company?

Alphial is a private company. It is classified as corporate owned and is currently operating.

When was Alphial founded?

Alphial was founded in 1964. It employs 51 to 100 people.

Where is Alphial based?

Alphial is headquartered in Treviglio, Italy, in the Europe region.

How does Alphial make money?

One revenue line is on record: pharmaceutical Glass Packaging.

Who are Alphial's main competitors?

Direct peers on record are Gerresheimer AG, Stevanato Group, DWK Life Sciences, Schott AG (Schott Pharma) and Nipro Corporation. AptarGroup is listed as an emerging player. Broad incumbents are Becton, Dickinson and Company (BD), Corning Incorporated, West Pharmaceutical Services and SGD Pharma.

Does Alphial have an API?

No public API is recorded for Alphial.

What industry is Alphial in?

Alphial's product category is Pharmaceutical Glass Packaging. Its primary akta.pro industry code is IMALAEAB, Pharmaceutical & Medical Glass Packaging (Vials, Ampoules, Syringes), with a secondary code of IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules). Its NAICS code is 327213 and its SIC code is 3221.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals